Zevra Therapeutics Inc (ZVRA)
9.22
+0.09
(+0.99%)
USD |
NASDAQ |
Nov 22, 09:37
Zevra Therapeutics Profit Margin (Quarterly): -899.2% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -899.2% |
| June 30, 2024 | -447.9% |
| March 31, 2024 | -485.3% |
| December 31, 2023 | -154.0% |
| September 30, 2023 | -358.1% |
| June 30, 2023 | -30.38% |
| March 31, 2023 | -416.2% |
| December 31, 2022 | |
| September 30, 2022 | -230.2% |
| June 30, 2022 | -1.85K% |
| March 31, 2022 | -47.01% |
| Date | Value |
|---|---|
| December 31, 2021 | -104.7% |
| September 30, 2021 | -89.52% |
| June 30, 2021 | 51.75% |
| March 31, 2021 | -84.97% |
| December 31, 2020 | -205.2% |
| September 30, 2020 | -156.3% |
| June 30, 2020 | 12.43% |
| March 31, 2020 | -275.4% |
| December 31, 2019 | -438.7% |
| September 30, 2019 | 26.72% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-1.85K%
Minimum
Jun 2022
51.75%
Maximum
Jun 2021
-326.8%
Average
-205.2%
Median
Dec 2020
Profit Margin (Quarterly) Benchmarks
| Ionis Pharmaceuticals Inc | -105.0% |
| Vanda Pharmaceuticals Inc | -11.17% |
| BioCardia Inc | -- |
| Xeris Biopharma Holdings Inc | -29.00% |
| Instil Bio Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -159.9% |
| Return on Assets | -56.14% |
| Return on Invested Capital | -85.03% |
| Gross Profit Margin (Quarterly) | 37.67% |
| Operating Margin (Quarterly) | -739.0% |
| Return on Net Operating Assets | -113.3% |